Ampio Pharmaceuticals Inc.

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41. RxSight shares jumped 20% to $44.31 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Harpoon Therapeutics, Inc. (NASDAQ: HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash. Ambrx Biopharma Inc. (NASDAQ: AMAM) jumped 98.1% to $27.00 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value of approximately $2 billion. Spectaire Holdings Inc. (NASDAQ: SPEC) jumped 75.2% to $2.96. Nkarta, Inc. (NASDAQ: NKTX) rose 51% to $9.17 as the company announced updated corporate presentation to reflect business and strategic update. Universe Pharmaceuticals INC (NASDAQ: UPC) gained 42% to $2.22. Elevation Oncology, Inc. (NASDAQ: ELEV) jumped 39.2% to $1.2193. NexImmune, Inc. (NASDAQ: NEXI) rose 34.7% to $8.32. Praxis Precision Medicines, Inc. (NASDAQ: PRAX) rose 34% to $33.76 as the company issued update on advancing clinical stage portfolio. QuantaSing Group Limited (NASDAQ: QSG) gained 31% to $2.0563. Butterfly Network, Inc. (NASDAQ: BFLY) rose 29.7% to $1.31 as the company announced FDA clearance of handheld ultrasound system, Butterfly iQ3. Venus Concept Inc. (NASDAQ: VERO) climbed 28% to $1.51. Ardelyx, Inc. (NASDAQ: ARDX) gained 25.5% to $7.73 after the company provided an update on its progress in 2023 and initial expectations for 2024. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 20.8% to $7.36 after the company issued preliminary Q4 revenue guidance above estimates. Also the company said it is approaching positive EPS and cash flow in 2H 2025. Axonics, Inc. (NASDAQ: AXNX) jumped 19.9% to $69.03 after the company announced a deal to be acquired by Boston Scientific. Crocs, Inc. (NASDAQ: CROX) jumped 18.8% to $102.69 after the company issued strong Q4 and full year 2023 guidance. LendingTree, Inc. (NASDAQ: TREE) ...

Related tickers: SHPH, PACB, HARP, QSG, AMPE, SILK, NAK, ZJYL, ELEV, FSLY, OPK, TCJH, PRTA, VERO, BCRX, IVP, RVNC, NKTX, UPC, BFLY, SGD, ARDX, PRAX, CROX, BNZI, DADA, VINC, CYCC, BSGM, NEXI, DVAX, AREN, BHG, SPEC, RGNX, AMAM, TREE, STTK, RXST, BA, AVDL, ARBK, CMC, SNMP, LMDX, FNA, MTC, DTC, SPR, UPWK, STSS, WWW, AXNX.

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th. LumiraDx shares dipped 30.5% to $0.0239 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Harpoon Therapeutics, Inc.(NASDAQ: HARP) gained 98.6% to $20.95 in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share. Vincerx Pharma, Inc. (NASDAQ: VINC) shares rose 56.3% to $1.86 in pre-market trading after the company announced compelling clinical efficacy of enitociclib in combination with venetoclax and prednisone in lymphoma. Spectaire Holdings Inc. (NASDAQ: SPEC) shares gained 46.6% to $2.48 in pre-market trading after gaining 7% on Friday. Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares gained 36.5% to $3.40 in pre-market trading after jumping over 10% on Friday. Vision Marine Technologies Inc. (NASDAQ:

Related tickers: LMDX, STSS, CYCC, HSCS, SPEC, BREA, SPR, SGD, AMPE, BNZI, CRGE, NSTG, HRTX, AREN, FTFT, HARP, VMAR, VINC, AIMD, EFTR.